Sanil Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 1989.
1989 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Sanil Pharmaceuticals Private Limited

Sanil Pharmaceuticals Private Limited, a active private limited company, was established on 06 October 1989 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239KA1989PTC010426. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Employing 6 professional, Its leadership includes Ishaan Pejavar Rao (Director), Nandan Pejavar Rao (Director), Nilima Dayanand Rao (Director). Past directors included Mohini Dayanand Rao, Ishaan Pejavar Rao, Nandan Pejavar Rao. It holds no open charges and ₹1.97 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.13/1(Old No.90/1),18Th Cross 19Th Main, 1St Block, Rajaji Nagar,, Bengaluru, Karnataka, 560010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239KA1989PTC010426

  • Registration Number

    010426

  • Incorporation Date

    06 October 1989

  • Authorized Capital

    ₹4.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 36 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.97 Cr
  • Revenue Growth **** -99.24%
  • Profit Growth **** -47.77%
  • Ebitda **** 68.80%
  • Net Worth -31.12%
  • Total Assets -50.05%
Company report

Sanil Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sanil Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sanil Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ishaan Pejavar Rao Director 24 Oct 2018 Current
Nandan Pejavar Rao Director 24 Oct 2018 Current
Nilima Dayanand Rao Director 30 Sep 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 11 Jun 2020 Past
Pramod Abcsdd Additional Director 24 Sep 2019 Past
Pramod Abcsdd Additional Director 24 Sep 2019 Past
Pramod Abcsdd Director 05 Sep 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanil Pharmaceuticals.

Sanil Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.24% decrease. The company also saw a substantial fall in profitability, with a 47.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.12%.

Sanil Pharmaceuticals revenue growth over time
Sanil Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -99.24%
*******
*******
*******
*******
Revenue from Operations
*******
 -100.00%
*******
*******
*******
*******
Total Assets
*******
 -50.05%
*******
*******
*******
*******
Profit or Loss
*******
 -47.77%
*******
*******
*******
*******
Net Worth
*******
 -31.12%
*******
*******
*******
*******
EBITDA
*******
 68.80%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanil Pharmaceuticals?

Unlock access to Sanil Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹19,683,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.66 Cr
  • Karnataka State Financial Corporation : 0.18 Cr
  • Can Fin Homes Limited : 0.14 Cr
Latest Charge Details
Date Lender Amount Status
23 Jul 2015 Canara Bank ₹3.89 M Satisfied
31 Mar 2012 Canara Bank ₹0.69 M Satisfied
17 Jan 2003 Canara Bank ₹1.00 Cr Satisfied
29 Oct 1997 Can Fin Homes Limited ₹1.35 M Satisfied
11 Jun 1997 Canara Bank ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sanil Pharmaceuticals?

Sanil Pharmaceuticals has a workforce of 6 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanil Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanil Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Sanil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sanil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Charges

    A charge registered on 23 Jul 2015 via Charge ID 10616058 with Canara Bank was fully satisfied on 23 May 2019. was recorded as a recent event.

  • Director Appointment

    Ishaan Pejavar Rao was appointed as a Director was appointed as a Director on 24 Oct 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Nandan Pejavar Rao was appointed as a Director was appointed as a Director on 24 Oct 2018 & has been associated with this company since 7 years 4 months . was completed.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 3.89 M with Charge ID 10616058 was registered on 23 Jul 2015. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sanil Pharmaceuticals Private Limited?

The CIN of Sanil Pharmaceuticals Private Limited is U24239KA1989PTC010426.

Where is Sanil Pharmaceuticals Private Limited headquartered?

Sanil Pharmaceuticals Private Limited is headquartered at No.13/1(Old No.90/1),18Th Cross 19Th Main, 1St Block, Rajaji Nagar,, Bengaluru, Karnataka, 560010.

When was Sanil Pharmaceuticals Private Limited incorporated?

Sanil Pharmaceuticals Private Limited was incorporated on 06 October 1989.

Who are the current directors of Sanil Pharmaceuticals Private Limited?

The current directors of Sanil Pharmaceuticals Private Limited are

What is the primary industry of Sanil Pharmaceuticals Private Limited?

The primary industry of Sanil Pharmaceuticals Private Limited is Manufacturing.

Is Sanil Pharmaceuticals Private Limited a listed company?

Sanil Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sanil Pharmaceuticals Private Limited?

The authorized capital of Sanil Pharmaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Sanil Pharmaceuticals Private Limited?

The compliance status of Sanil Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available